lansoprazole has been researched along with Prostatic Hyperplasia in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagcivan, I | 1 |
| Gökçe, G | 1 |
| Ayan, S | 1 |
| Yildirim, S | 1 |
| Saraç, B | 1 |
| Kiliçarslan, H | 1 |
| Sarioglu, Y | 1 |
1 other study available for lansoprazole and Prostatic Hyperplasia
| Article | Year |
|---|---|
Hydrogen-potassium ATPase inhibitors induce relaxation on rabbit prostatic strips in vitro.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Disease Models, Animal; Enzyme Inhibitors; H(+)-K( | 2002 |